| 國立臺灣大學 |
2008-08 |
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response
|
Wu, Jenn-Yu; Shang-GinWu; Chih-HsinYang; Gow, Chien-Hung; Chang, Yih-Leong |
| 臺大學術典藏 |
2018-09-10T07:05:53Z |
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response
|
Wu, J.-Y.; Wu, S.-G.; Yang, C.-H.; Gow, C.-H.; Chang, Y.-L.; Yu, C.-J.; Shin, J.-Y.; Yang, P.-C.; YIH-LEONG CHANG; CHONG-JEN YU; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-03-06T05:26:31Z |
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response
|
Wu J.-Y.; Wu S.-G.; Yang C.-H.; Gow C.-H.; YIH-LEONG CHANG; Yu C.-J.; Shin J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-07T06:56:45Z |
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response
|
Wu J.-Y.;Wu S.-G.;Yang C.-H.;Gow C.-H.;Yih-Leong Chang;Yu C.-J.;Shin J.-Y.;Yang P.-C.; Wu J.-Y.; Wu S.-G.; Yang C.-H.; Gow C.-H.; YIH-LEONG CHANG; Yu C.-J.; Shin J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:23Z |
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response
|
Yang P.-C.;Shin J.-Y;Yu C.-J;Chang Y.-L;Gow C.-H;Chih-Hsin Yang;Wu S.-G;Wu J.-Y; Wu J.-Y; Wu S.-G; CHIH-HSIN YANG; Gow C.-H; Chang Y.-L; Yu C.-J; Shin J.-Y; Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T08:25:31Z |
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response
|
Wu J.-Y.; SHANG-GIN WU; Yang C.-H.; Gow C.-H.; Chang Y.-L.; Yu C.-J.; Shin J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-12-02T02:34:34Z |
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response
|
Wu J.-Y.;Wu S.-G.;Yang C.-H.;Gow C.-H.;Chang Y.-L.;Yu C.-J.;Shin J.-Y.;Pan-Chyr Yang; Wu J.-Y.; Wu S.-G.; Yang C.-H.; Gow C.-H.; Chang Y.-L.; Yu C.-J.; Shin J.-Y.; PAN-CHYR YANG |
| 臺大學術典藏 |
2022-06-27T07:06:21Z |
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response
|
Wu J.-Y.; Wu S.-G.; Yang C.-H.; Gow C.-H.; Chang Y.-L.; CHONG-JEN YU; Shin J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-12-02T02:35:36Z |
Lung cancer: Diagnosis and staging
|
Lam W.K.;Pan-Chyr Yang; Lam W.K.; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-05-26T09:27:06Z |
Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1
|
Chmielecki J; Lin Y.-L; Pan Y; Wang L; De Stanchina E; Shien K; Aoe K; Toyooka S; Kiura K; Fernandez-Cuesta L; Fidias P; CHIH-HSIN YANG; Miller V.A; Riely G.J; Kris M.G; Engelman J.A; Vnencak-Jones C.L; Dias-Santagata D; Ladanyi M; Pao W.; Pao W.;Ladanyi M;Dias-Santagata D;Vnencak-Jones C.L;Engelman J.A;Kris M.G;Riely G.J;Miller V.A;Chih-Hsin Yang;Fidias P;Fernandez-Cuesta L;Kiura K;Toyooka S;Aoe K;Shien K;De Stanchina E;Wang L;Pan Y;Lin Y.-L;Chmielecki J;Moran T;Arcila M.E;Sequist L.V;Ohashi K; Ohashi K; Sequist L.V; Moran T; Arcila M.E |
